(a)
the name of the issuer of the shares,
Medistim (ISIN: NO0010159684)
(b)
the date on which the proportion of shares held
reached, exceeded or fell below the thresholds set in
the Securities Trading Act section 4-3 subsection (1),
2017-01-20
(c)
name of the entity subject to the disclosure
obligation, including the name of the shareholder,
Swedbank Robur Fonder AB
Fund:
Ny Teknik (Short Name: BTI)
(d)
the number of shares the notification encompasses,
Total: 1 023 112
(e)
the subsequent situation with regard to voting rights,
including the percentage of the votes and shares of
the company held by the entity concerned,
Votes (%):5.58
Shares (%):5.58
(f)
what percentage of the votes and shares of the company
the entity concerned holds in the form of rights to
shares,
0
(g)
the circumstance that triggered the disclosure
obligation and whether such circumstance applied to
the entity concerned himself or to any related party
as mentioned in the Securities Trading Act section 2-5,
Acquisition of shares.
(h)
the chain of controlled undertakings through which the
shares or rights are owned,
Fund management
(i)
where the notification concerns rights to shares as
mentioned in the Securities Trading Act section 4-3
subsection (4) the notification shall also contain a
description of the rights, including information on
the date and time that the rights will or can be
exercised and the date and time of their expiry.
0
Please contact Mia Metso Ekberg
(mia.metso.ekberg@swedbankrobur.se) or Ulrika Ersson
(ulrika.ersson@swedbankrobur.se) if you have questions.
Disclosures
Swedbank Robur Fonder AB